We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Merck & Co., Inc. stands third among them. Merck & Co., Inc. (NYSE:MRK), a global leader in pharmaceuticals ...

Keytruda is not chemotherapy. It’s a type of treatment called immunotherapy. It works with the body’s immune system, helping T cells fight cancer cells. With immunotherapy, the body’s immune system ...

Aug 27 (Reuters) - Amazon.com (AMZN.O), opens new tab will extend its corporate staff programs, including pay structure and benefits, to U.S. corporate employees at its Whole Foods chain of ...

**Note: UNM allowed limited access to the parking structure on Thursday, one day after this story originally was published. ALBUQUERQUE, N.M. (KRQE) – A Lobo Alert went out Wednesday morning, ...

PDS0101 and pembrolizumab combination achieved a median overall survival of 39.3 months in HPV16-positive head and neck cancer patients with a CPS of at least 1. The VERSATILE-002 trial showed ...

(Reuters) -Amazon.com will extend its corporate staff programs, including pay structure and benefits, to U.S. corporate employees at its Whole Foods chain of supermarkets, aiming to integrate its ...

The City of Plattsburgh Fire Department has confirmed that a reported structure fire on Margaret Street was actually caused by smoke from incense. ELEVATED HEART RATE. THEY WERE ALL TAKEN TO THE ...

Psychotherapy leads to measurable changes in brain structure. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Münster have demonstrated this for the first time in ...

(UPDATE) Great Falls Fire Rescue Great said in a news release on Tuesday that the fire was in a shed; all occupants were safely out of the house when firefighters arrived. The shed, which was located ...

LAKESIDE - Crews battled a structure fire at the Spinnaker Casino Bar and Grill off of U.S. Highway 93 in Lakeside on Monday morning. Somers Fire Chief Tom Havens tells MTN crews responded to the ...

PDS Biotech has reported final phase 2 data on PDS0101 in the tough-to-treat head and neck cancer setting, linking a combination of the immunotherapy and Keytruda to median overall survival (OS) of 39 ...